Can a smartphone app replace the gym for diabetes control?

NCT ID NCT07685080

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study compares two 20-week exercise programs for adults aged 30-65 with both type 2 diabetes and obesity. One group attends supervised, in-person sessions twice a week, while another follows the same plan through a mobile app. A third group receives standard medical care only. All participants wear a Fitbit to track activity. The goal is to see if app-guided exercise can improve blood sugar, body composition, and quality of life as effectively as supervised training, potentially offering a more accessible option for long-term disease management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
supervised and unsupervised mHealth-based exercise interventions
What this could lead to
If successful, this could show that app-guided exercise is as effective as in-person training for managing type 2 diabetes and obesity, offering a scalable, low-cost option for primary care.
What could go wrong
This is a relatively small, single-center trial. The 20-week program may not be long enough to see lasting changes, and adherence to unsupervised exercise could be low, limiting the results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Insulin Resistance Motor Activity Obesity obesity disorder Sedentary Behavior type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • José Manuel Jurado Castro

    Osuna, Sevilla, 41640, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.